therapeutics 相關
廣告
搜尋結果
MDMA Drug for PTSD Fails to Get Backing From FDA Advisers
Bloomberg· 3 小時前Have a confidential tip for our reporters? The psychedelic drug MDMA failed to get backing from ...
Jim Cramer says don't sell Tesla, but stay away from this biotech stock
CNBC· 9 小時前Tesla : Shares were slightly lower Tuesday. CNBC reported earlier in the day that CEO Elon Musk ...
盤前飆升5%!減肥藥新貴Viking(VKTX.US)NASH候選藥VK2809大獲成功
阿思達克財經網· 11 小時前智通財經APP獲悉,減肥藥物開發商Viking Therapeutics(VKTX.US)公佈了治療非酒精性脂肪性肝炎(NASH)的 ...
美股開市前:英特爾升約2% AI晶片便宜賣 台積電跌1%
Investing.com HK via Yahoo財經香港· 11 小時前Investing.com - 周二(4日)開市前,美股股指期貨下跌,道指期貨跌約100點,市場靜待稍晚的職位空缺數 ...
FDA panel to review psychedelic drug MDMA for first time
Reuters· 13 小時前It follows a decades-long push by advocates who say drugs like MDMA can treat mental health ...
樂迦攜手新加坡MediSix 共同開發頂尖CAR-T療法 - 鏡週刊 Mirror Media
鏡傳媒· 15 小時前再生醫療雙法今(4)日三讀通過,非醫療機構不得執行再生醫療,而執行再生技術前應進行並完成人體試驗 ...
CNBC Daily Open: GameStop can't stop, Dow drops
CNBC· 18 小時前A screen displays the logo and trading information for GameStop on the floor of the New York ...
Domestic drug R&D makes positive strides
China Daily· 20 小時前Development of innovative drugs in China has gathered momentum in recent years thanks to ramped-up research spending and ...
建銀國際:康方生物(09926)股價可望進一步反彈 目標價56.2元
infocast via Yahoo財經香港· 23 小時前建銀國際發表研究報告,維持康方生物(09926)目標價56.2港元,相當於2024財年股價與總收入的18.7倍,高於內地主要生科公司10.4倍的行業平均,並維持「優於大 ...
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO
Reuters· 1 日前Rapport Therapeutics is targeting a valuation of about $637 million in its initial public offering in ...
therapeutics 相關
廣告